Joseph P. Kitzmiller MD, PhD, FCP

Joseph as an NIH Translational Scholar in Pharmacogenomics and faculty member at The Ohio State University (Colleges of Engineering and Medicine), Joseph Kitzmiller, M.D., Ph.D., F.C.P. focuses his research effort on investigating the interplay among genetics and cardiovascular pharmacotherapies. With active funding from the American Heart Association and the National Institute of General Medical Sciences, Dr. Kitzmiller leads basic, translational, and clinical research of the largest classes of cardiovascular medications, statins and beta-blockers.

He is a board-certified Pharmacologist (American Board of Clinical Pharmacology) and supervises implementation of clinical pharmacogenetic testing for Gnome Diagnostics and drug-development pharmaceutical trials for Ohio Clinical Trials. At the Ohio State University, he is Associate Director of the Center for Pharmacogenomics and Director of the Clinical Pharmacology Fellowship Training Program (1 of only 9 programs accredited by The American Board of Clinical Pharmacology). In 2014, Dr. Kitzmiller completed Physician Training and Certification in Age Management Medicine.